---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-21-018477"
form_type: "8-K"
ticker: "CSBR"
cik: "0000771856"
company_name: "CHAMPIONS ONCOLOGY, INC."
filed_at: "2021-09-13T23:59:59+00:00"
generated_at: "2026-06-29T04:21:22.493742+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Champions Oncology Q1 revenue record $11.3M, up 18% YoY; non-GAAP op income $422k

## Summary
- Record quarterly revenue of $11.3M, +17.9% YoY, driven by larger studies and platform expansion.
- GAAP operating loss of $175k; non-GAAP operating income of $422k, excluding $280k stock comp and $317k D&A.
- Gross margin improved to 52.0% from 44.1% as more lab work was performed internally.
- Cash position $4.0M with no debt; net cash from operations $216k in the quarter.
- Validated 6 therapeutic discovery targets; SaaS platform Lumin Bioinformatics adding new users.

## SEC filing metadata
- accession: 0001628280-21-018477
- form_type: 8-K
- ticker: CSBR
- cik: 0000771856
- company_name: CHAMPIONS ONCOLOGY, INC.
- filed_at: 2021-09-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/771856/000162828021018477/0001628280-21-018477-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/771856/000162828021018477/csbr-20210913.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-21-018477
- JSON: https://secwatch.observer/filing/0001628280-21-018477.json
- Plain text: https://secwatch.observer/filing/0001628280-21-018477.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.